19
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      CRISPR-based tools: alternative methods for the diagnosis of COVID-19

      review-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Highlights

          • Testing for SARS-CoV-2 is crucial as it enables the detection and isolation of infected individuals.

          • Although RT-qPCR is the gold standard method for COVID-19 diagnosis, it has some drawbacks in meeting the current needs.

          • CRISPR-based methods have been used for the detection of pathogens including SARS-CoV-2.

          • These methods have the potential to aid RT-qPCR in the fight against COVID-19.

          Abstract

          The recently emerged severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) spread all over the world rapidly and caused a global pandemic. To prevent the virus from spreading to more individuals, it is of great importance to identify and isolate infected individuals through testing. Reverse transcription-quantitative polymerase chain reaction (RT-qPCR) is the gold standard method for the diagnosis of coronavirus disease (COVID-19) worldwide. However, performing RT-qPCR is limited to centralized laboratories because of the need for sophisticated laboratory equipment and skilled personnel. Further, it can sometimes give false negative or uncertain results. Recently, new methods have been developed for nucleic acid detection and pathogen diagnosis using CRISPR-Cas systems. These methods present rapid and cost-effective diagnostic platforms that provide high sensitivity and specificity without the need for complex instrumentation. Using the CRISPR-based SARS-CoV-2 detection methods, it is possible to increase the number of daily tests in existing laboratories, reduce false negative or uncertain result rates obtained with RT-qPCR, and perform testing in resource-limited settings or at points of need where performing RT-qPCR is not feasible. Here, we briefly describe the RT-qPCR method, and discuss its limitations in meeting the current diagnostic needs. We explain how the unique properties of various CRISPR-associated enzymes are utilized for nucleic acid detection and pathogen diagnosis. Then, we highlight the important features of CRISPR-based diagnostic methods developed for SARS-CoV-2 detection. Finally, we examine the advantages and limitations of these methods, and discuss how they can contribute to improving the efficiency of the current testing systems for combating SARS-CoV-2.

          Related collections

          Author and article information

          Journal
          Clin Biochem
          Clin Biochem
          Clinical Biochemistry
          The Canadian Society of Clinical Chemists. Published by Elsevier Inc.
          0009-9120
          1873-2933
          9 January 2021
          9 January 2021
          Affiliations
          [a ]Faculty of Medicine, Hacettepe University, Ankara 06100, Turkey
          [b ]Faculty of Pharmacy, Hacettepe University, Ankara 06100, Turkey
          [c ]Department of Medical Microbiology, Faculty of Medicine, Hacettepe University, Ankara 06100, Turkey
          [d ]Department of Biomedical Engineering, Near East University, Nicosia, 10 Mersin, Turkey
          Author notes
          [* ]Corresponding author.
          Article
          S0009-9120(21)00001-1
          10.1016/j.clinbiochem.2020.12.011
          7796800
          33428900
          529f41f8-766d-45bd-90a4-025236976d9d
          © 2021 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.

          Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.

          History
          : 16 September 2020
          : 29 December 2020
          : 31 December 2020
          Categories
          Review

          crispr-based diagnostics,sars-cov-2,nucleic acid detection,covid-19,collateral cleavage

          Comments

          Comment on this article